Crown Princess Victoria's Child and Youth Hospital, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Division of Children's and Women's Health, Department of Biomedical and Clinical Sciences, Faculty of Health Sciences, Linköping University, Linköping, Sweden.
Pediatr Cardiol. 2022 Aug;43(6):1286-1297. doi: 10.1007/s00246-022-02850-y. Epub 2022 Mar 25.
Intrauterine growth restriction (IUGR) may directly affect cardiovascular function in early life. Longitudinal data on left ventricular longitudinal strain (LVLS), a key measure of cardiac function independent of body size, is not available. We hypothesize impaired cardiac function among IUGR newborns and persistence of the impairment until age 3 months.
This is a prospective cohort study of consecutive pregnancies where IUGR was identified at 18-38 weeks gestational age (GA) with healthy controls randomly selected at 18-20 weeks GA. Echocardiograms were performed at birth and at age 3-4 months, and then compared.
At birth, mean (SD) LVLS did not differ between the IUGR group [N = 19; - 15.76 (3.12) %] and controls [N = 35; - 15.53 (3.56) %]. The IUGR group demonstrated no significant change in LVLS at age 3-4 months [- 17.80 (3.82) %], while the control group [- 20.91 (3.31) %] showed a significant increase (P < 0.001). Thus, LVLS was lower in the IUGR group at age 3-4 months (P = 0.003).
The lack of increase in LVLS may suggest that IUGR has a direct impact on cardiac function as early as during the first months of life. Trial registration Clinical trials.gov Identifier: NCT02583763, registration October 22, 2015. Retrospectively registered September 2014-October 2015, thereafter, registered prospectively.
宫内生长受限(IUGR)可能直接影响生命早期的心血管功能。左心室纵向应变(LVLS)的纵向数据(LVLS)是心脏功能的关键指标,不依赖于身体大小,目前尚不可用。我们假设 IUGR 新生儿的心脏功能受损,并且这种损伤会持续到 3 个月大。
这是一项连续妊娠的前瞻性队列研究,其中 18-38 周妊娠(GA)时发现 IUGR,随机选择 18-20 周 GA 的健康对照组。在出生时和 3-4 个月时进行超声心动图检查,然后进行比较。
在出生时,IUGR 组 [N=19;-15.76(3.12)%] 和对照组 [N=35;-15.53(3.56)%] 的 LVLS 平均值(SD)无差异。IUGR 组在 3-4 个月时 LVLS 无显著变化[-17.80(3.82)%],而对照组[-20.91(3.31)%]则有显著增加(P<0.001)。因此,IUGR 组在 3-4 个月时的 LVLS 较低(P=0.003)。
LVLS 无增加可能表明,IUGR 早在生命的第一个月就对心脏功能产生直接影响。
临床试验.gov 标识符:NCT02583763,注册日期 2015 年 10 月 22 日。2014 年 9 月至 2015 年 10 月回顾性注册,此后前瞻性注册。